Graves' hyperthyroidism, ophthalmopathy and pretibial myxedema may be components of a multi-system autoimmune disorder

References

• Burch H B, Wartofsky L. Graves' ophthalmopathy: current concepts regarding pathogenesis and management. Endocr Revs 1993; 14: 747–793
   PubMed Web of Science ®Google Scholar
• Kiljanski J, Wall J R. Is the ocular muscle cell a target of the immune system in endocrine ophthalmopathy?-. Pro. Intl Arch Allergy Immunol 1995; 106: 204–212
   PubMed Web of Science ®Google Scholar
• Toccafondi R, Rotella C M, Zonferati R, Tanini A. Humoral factors in Graves' ophthalmopathy. Thyroid Autoimmunity, A Pinchera, S H Ingbar, J M McKenzie, G F Fenzi. Plenum Press, New York 1987; 99–108
   Google Scholar
• Bahn R, Smith T J, Gorman C A. The central role of the fibroblast in the pathogenesis of extrathyroidal manifestations of Graves' disease. Acta Endocrinol (Copenh) 1989; 121: 75–81
   Google Scholar
• Wall J R, Trewin A, Fang S L, Ingbar S H, Braverman L E. Studies of immunoreactivity to human lacrimal gland fractions in patients with ophthalmic Graves' disease. J Endocrinol Invest 1978; 1: 253–258
   PubMed Web of Science ®Google Scholar
• Committees of Regional Thyroid Associations. Classification of eye changes of Graves' disease. Thyroid 1992; 2: 235–236
   PubMed Web of Science ®Google Scholar
• Mengistu M, Laryea E, Miller A, Wall J R. Clinical significance of a new autoantibody against a human eye muscle soluble antigen, detected by immunofluorescence. Clin Exp Immunol 1986; 65: 19–27
   PubMed Web of Science ®Google Scholar
• Salvi M, Miller A, Wall J R. Human orbital tissue and thyroid membranes express a 64 kDa protein which is recognized by autoantibodies in the serum of patients with thyroid-associated ophthalmopathy. FEBS Lett 1988; 232: 135–139
   PubMed Web of Science ®Google Scholar
• Wall J R, Scalise D, Hayes M, Stolarski C, Sato M, Salvi M, Nebes V. Native gel electrophoresis of the 64 kDa protein shows that it is eye muscle specific and an important target for autoantibodies in patients with thyroid-associated ophthalmopathy. J Clin Endocrinol Metabol 1994; 80: 1226–1232
   Google Scholar
• Teboul N, Triller H, Chung F, Bernard N, Zhang Z G, Wall J R. Muscle and species reactivity of mouse monoclonal antibodies to human eye muscle membrane antigens. Clin Immunol Immunopathol 1991; 59: 104–116
   PubMedGoogle Scholar
• Nakamura R. Autoantibodies to nuclear antigens (ANA). Advances in Laboratory Tests and Significance in Rheumatic Disease2nd edn. Am Soc Clin Pathologists Press, Chicago 1985; 3–6
   Google Scholar
• Konstadoulakis M M, Kroubouzos G, Tosca A, Piperingos G, Marafelia P, Konstadoulakis M, et al. Thyroid autoantibodies in the subsets of lupus erythematosus: correlation with other autoantibodies and thyroid function. Thyroidology 1993; 5: 1–7
   PubMedGoogle Scholar
• Gordon T, Isenberg D. Organ specific and multisystem autoimmune disease: Part of a spectrum which may coexist in the same patient. Clin Rheumatol 1990; 9: 401–403
   PubMedGoogle Scholar
• McCombe P A, Chalk J B, Pender M R. Familial occurrence of multiple sclerosis with thyroid diseases and systemic lupus erythematosus. J Neurol Science 1990; 97: 163–171
   PubMedGoogle Scholar
• Loviselli A, Velluzzi F, Pala R, Marcello A, Nurchis P, Mathieu A, et al. A family study of the antiphospholipid syndrome associated with other autoimmune diseases. J Rheumatol 1992; 19: 1393–1396
   PubMedGoogle Scholar
• McDermott M T, West S G, Emlen J W, Kidd G S. Antideoxyribonucleic acid antibodies in Graves' disease. J Clin Endocrinol Metabol 1990; 71: 509–511
   PubMedGoogle Scholar
• Bartalena L, Martino E, Grasso L. Circulating antibodies to DNA-related antigens in patients with autoimmune thyroid disorders. Autoimmunity 1992; 14: 33–36
   PubMedGoogle Scholar
• Loviselli A, Velluzi F, Pala R, Marcello E, Nurchis P, Mathieu A, et al. Circulating antibodies to DNA-related antigens in patients with autoimmune thyroid disorders. Autoimmunity 1992; 14: 33–36
   PubMedGoogle Scholar
• Arnaout M A, Nasarallah N S, el-Khateeb M S. Prevalence of abnormal thyroid function tests in connective tissue disease. Scand J Rheumatol 1994; 23: 128–132
   PubMed Web of Science ®Google Scholar
• Salvi M, De Chiara F, Gardini E, Minelli R, Bianconi L, Alnovi A, et al. Echocardiographic diagnosis of pretibial myxedema in patients with autoimmune thyroid disease. Acta Endocrinol (Copenh) 1994; 131: 113–119
   Google Scholar
• Dudgeon L S, Urquhart A L. Lymphorrhages in the muscle in exophthalmic goitre. Brain 1975; 49: 182–186
   Google Scholar
• Hiromatsu Y, Sato M, Tanaka K, Shoji S, Nonaka K, Chinami M, Fukazawa H. Significance of anti-eye muscle antibody in patients with thyroid-associated ophthalmopathy by quantitative Western blot. Autoimmunity 1993; 14: 1–8
   PubMed Web of Science ®Google Scholar
• Chang T C, Chang T J, Huang Y S, Hua K M, Su R J, Kao S CS. Identification of autoantigen recognized by autoimmune ophthalmopathy sera with immunoblotting correlated with orbital computed tomography. Clin Immunol Immunopathol 1992; 65: 161–166
   PubMedGoogle Scholar
• Hiromatsu Y, Fukazawa H, Guinard F, Salvi M, How J, Wall J R. A thyroid cytotoxic antibody that crossreacts with an eye muscle cell surface antigen may be the cause of thyroid associated ophthalmopathy. J Clin Endocrinol Metabol 1988; 67: 565–570
   PubMed Web of Science ®Google Scholar
• Hiromatsu Y, Fukazawa H, How J, Wall J R. Antibody-dependent cell-mediated cytotoxicity against human eye muscle cells and orbital fibroblasts in Graves' ophthalmopathy—roles of Class IIMHC antigen expression and-interferon action on effector and target cells. Clin Exp Immunol 1987; 70: 593–603
   PubMed Web of Science ®Google Scholar
• Hiromatsu Y, Cadarso L, Salvi M, Wall J R. Significance of cytotoxic eye muscle antibodies in patients with thyroid-associated ophthalmopathy. Autoimmunity 1990; 5: 205–213
   PubMed Web of Science ®Google Scholar
• Bahn R S, Gorman C A, Johnson C M, Smith T J. Presence of antibodies in the sera of patients with Graves' disease recognizing a 23 kilodalton fibroblast protein. J Clin Endocrinol Metabol 1989; 69: 622–628
   PubMed Web of Science ®Google Scholar
• Feliciello A, Porcellini A, Ciullo I, Bonavolontà G, Avvedimento E V, Fenzi G. Expression of thyrotropin-receptor mRNA in healthy and Graves' disease retro-orbital tissue. Lancet 1993; 1: 337–338
   Google Scholar
• Heufelder A E, Dutton C M, Sarkar G, Donovan K A, Bahn R S. Detection of TSH receptor RNA in cultured fibroblasts from patients with Graves' ophthalmopathy and pretibial dermopathy. Thyroid 1993; 3: 297–300
   PubMed Web of Science ®Google Scholar
• Bataille N, Schmitt N, Aumercier-Maes P, Ollivier B, Lucas-Heron B, Lestienne P. Molecular cloning of human calmitine, a mitochondrial calcium binding protein, reveals identitiy with calsequestrin. Biochem Biophys Res Comm 1994; 203: 1477–1482
   PubMedGoogle Scholar
• Jin J P, Wang K. Cloning, expression, and protein interaction of human nebulin fragments composed of varying numbers of sequence modules. J Biol Chem 1991; 266: 21215–21223
   PubMedGoogle Scholar
• Sany J. Pathogenic role of antinuclear antibodies in lupus disease. Ann Méd Int 1990; 141: 222–226
   PubMedGoogle Scholar
• Raz E, Ben-Basat H, Davidi T, Shlomai Z, Eilat D. Cross-reactions of anti-DNA autoantibodies with cell surface proteins. Europ J Immunol 1993; 23: 383–390
   PubMed Web of Science ®Google Scholar